catecholamine cerebral artery heart a b s t r a c t
Introduction
Chronic increased sympathetic activation occurs in many situations, including obesity, sleep apnea, mental stress, and hypertension, promoting the development of cardiovascular diseases through sustained stimulation of adrenergic stimulation of ␤AR in the heart. In fact, ␤AR blockade consistently improves cardiac function and survival in patients with heart failure. 10, 11 By contrast, ␣-adrenergic receptor blockades is an effective antihypertensive approach, but may actually increase the risk of cardiovascular events, as shown in patients taking doxazosin in the ALLHAT (Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial) trial. 12 Use of the ␤AR blocker metoprolol during the perioperative period in patients with non-cardiac diseases was associated with an increased the risk of strokes and death. 13 These studies suggest that sympatholytic agents are unlikely to be accepted as a common regimen for the treatment of both the heart and the vasculature simultaneously. Based on these findings, overstimulation of ␤AR appears to have different effects on the heart and cerebral artery. Therefore, the focus of this review is to compare cardiac and vascular, effects of beta AR stimulation and effects on related signal transduction processes.
Effect of prolonged ␤AR stimulation on the heart
Long-term ␤AR activation by various stressors induces serious myocardial damages, including cardiac hypertrophy, necrosis/apoptosis, and fibrosis. 7, 9, [14] [15] [16] Cardiac hypertrophy is an independent cause of heart failure and major cause of morbidity and mortality throughout the world; thus, research and clinical interventions for cardiac hypertrophy have been extensively studied. [17] [18] [19] Once cardiac hypertrophy develops, it progresses to heart failure. 17 The underlying mechanisms associated with ␤AR overstimulation have been studied in vivo in heart tissue using isoproterenol (ISO)-treated models and in vitro in cultured cardiomyocytes. This ␤AR overstimulation represents an important hallmark of pathologic cardiac hypertrophy. 15, [20] [21] [22] [23] [24] ISO treatment increases oxidative stress, protein synthesis, proto-oncogene expression, and stimulation of mitogenactivated protein kinases. These events are caused by altered of electrical and mechanical capabilities that induce three modes of cell death: necrosis, apoptosis, and autophagy (see Table 1 ).
Furthermore, ISO treatment alters related signal transduction pathways. In the normal heart, ␤AR activation stimulates adenylyl cyclase activity via Gs protein-coupled receptors, which leads to the formation of cAMP. Increased cAMP elevates intracellular concentrations of Ca 2+ , which activates protein kinase A (PKA)-mediated phosphorylation of different Ca 2+ -handling proteins, producing positive inotropic effects in the heart. However, long-term ISO stimulation results in desensitization of the PKA-dependent receptor after previous phosphorylation, thus attenuating ␤AR-mediated response. 15, 25, 26 Tse et al 26 showed that cardiac hypertrophy develops in rats treated chronically with ISO stimulation; further, these rats showed decreased magnitude and sensitivity of contractility in vitro in response to ISO stimulation. These effects were, related to biochemical alterations, including decreased numbers of ␤ARs, decreased sensitivity and magnitude of adenylate cyclase activity, and decreased cAMP formation. We also clearly showed that PKA activity, but not protein kinase C (PKC) activity, in the rabbit heart decreased gradually with time after prolonged ␤AR stimulation. 15 In addition to the study of Tse et al, 26 underlying mechanisms of ␤AR desensitization to an agonist may be associated with an increased ␤AR kinase activity. 27 This possibility is supported by the finding that ␤AR stimulation can significantly increase the expression of ␤AR kinase 1, whereas ␤AR blockade decreases the expression. 28 
3.
Effect of prolonged ␤AR stimulation on the vasculature Despite massive studies on the effects of ISO treatment on the heart, few studies have been performed to evaluate its effects on the vasculature. Pathological cardiac hypertrophy caused by overstimulation of ␤AR is a potent, independent predictor of cerebrovascular events such as stroke. 29, 30 In diverse vessels, such as the femoral, pulmonary, and carotid arteries, acute stimulation of ␤AR induces vasodilation. 31 Long-term stimulation of ␤AR in arteries, however, can induce alterations in vascular contractility.
Previously, we demonstrated that prolonged ISO treatment in rabbits leads to abnormalities in the coronary arterial functions through alterations in the Ca 2+ -activated K + and inward-rectifier K + channels in smooth muscle cells. This implies a novel mechanism for vascular dysfunction during cardiac hypertrophy. 14, 32 With regard to the rat aorta, Davel et al 33 demonstrated that prolonged ISO stimulation induced endothelial dysfunction and increased vasoconstriction by phenylephrine, an ␣-adrenergic receptor agonist, due to endothelial dysfunction. They suggested that ISO treatment enhanced the vasoconstrictor response and increased oxidative stress via Endothelial Nitric Oxide Synthase (eNOS) uncoupling, through the ␤2AR/Gi␣ signaling pathway. 34 Interestingly, we found that ␤AR stimulation decreased transient Ca 2+ efflux and attenuated contraction in response to angiotensin II in the rabbit cerebral artery. 35 Possible mechanisms of abnormal response to vasoactivity in different arteries may be due to factors other than biochemical alterations, as shown in the heart. These include the possibility that vascular tissues are vulnerable to oxidative stress, which may disrupt the cytoskeleton further. 35 
4.
Differential modulation of the proteome in the heart and cerebral artery during ␤AR stimulation To help improve interventions for managing cerebrovascular events during cardiac hypertrophy, here we focus on differences between cardiac and vascular signaling during prolonged ␤AR stimulation.
Inducible proto-oncogenes encode nuclear transcription factors and activate promoters of many target genes playing a that have roles in cellular functions, adaptive processes, or cell death. [36] [37] [38] Prolonged ␤AR stimulation increases the phosphorylation of Extracellular signal-Regulated Kinase (ERK) increasing expression of c-fos and c-myc in the cerebral arteries, whereas only c-fos expression corresponds to the increased phosphorylation of ERK in the heart. Therefore, post-translational modulation appears to progress via different mechanisms in the heart and the cerebral artery. Although cardiac hypertrophy is not known to be a prerequisite for altered expression of proto-oncogenes in vivo, 39 ␤AR stimulates Gi-dependent PI3 kinase (PI3K) activity and cell growth. 40 In human erythroid progenitors cells, PKC␣ and PI3K␥ pathways are parallel and converge to activate the c-fos and c-myc genes. 41 In addition, decreased signaling of the Ras/Raf/MEK/ERK cascade in the cerebral artery during cardiac hypertrophy can interrupt the actin cytoskeletal network, because Ras/Raf/MEK/ERK is essential for actin-base cytoskeletal organization. 42, 43 In contrast, Ras and Raf are activated in the heart during cardiac hypertrophy, 44 and may roles in proliferation and transformation. Decreased PKA activity may possibly contribute indirectly to decreased expressions of the Ras/Raf/MEK/ERK signaling in the cerebral artery, because PKA activity is well known to innately correspond with Ras/Raf activation. 45 However, recent findings also demonstrated that PKA activation does not contribute to Ras/Raf activation. 44, 46 Thus we suggested that the underlying mechanism of vascular dysfunction resulting from the decreased expression levels of RhoA and ROCK1 proteins after ␤AR stimulation. 35 RhoA and ROCK1 are involved in actin-cytoskeletal organization and phosphorylation of myosin light chain producing smooth muscle contraction. 47 The contractility of vascular smooth muscle cells is widely regulated by the cytoskeletal proteome network. 48 Our previous study clearly shows that ␤AR stimulation disrupts the actin cytoskeletal proteome network through downregulation of RhoA/ROCK1 proteins attenuating angiotensin II-induced contraction in the cerebral artery. 35 Cardiac or cerebral remodeling by ␤AR stimulation may involve changes in cellular energy. However, there are a few studies of proteome analysis of ␤AR stimulated pathways in the heart and the cerebral artery; these studies, revealed similarities in the main response, including: apoptosis/necrosis, stress/energy, inflammation, and remodeling/fibrosis (also see Table 1 ). In the heart, a greater number of genes are altered in the category of energy or remodeling, whereas, a greater number of genes involved in cytoskeletal organization are altered in the cerebral artery.
Regarding oxidative stress, expression levels of several cytoprotective chaperones and protein maturation elements are significantly decreased in both the heart and the cerebral artery. Excessive levels of reactive oxygen species (ROS) results in oxidative stress, because the balance between production of ROS and activation of the antioxidant system is essential for controlling homeostasis. Sustained high levels of circulating catecholamines induced by stress can result in cardiotoxicity due to the production of oxygen free radicals. 49 This is supported by several recent findings demonstrating that ␤AR stimulation increase ROS production in the HEK293 cells, rat cardiac myocytes, and the rat aorta. [50] [51] [52] Increased oxidative stress can also lead to DNA damage. 35, 53 Interestingly, in either the heart or the cerebral artery, decreased levels of cytoprotective proteins, including heat shock protein 70/90 and stress-induced-phosphoprotein 1, are more likely due to cause deleterious effects 35, 54, 55 -rather than increased ROS production. Heat shock proteins are crucial to cellular defense and mitochondrial protection against oxidative stress; these are ubiquitous and highly conserved chaperones are associated with myocardial protection. 56 Oxidative stress activates several kinase signaling pathways, such as PKC, Mitogen-activated protein kinases (MAPK), and PI3K. 57 In particular, the Bcl-2 like protein 1 and Bak1, which are associated with mitochondria, are significantly altered in the heart. 54 These proteins induce apoptosis by regulating metabolite diffusion across the outer mitochondrial membrane. 58 Apoptosis during cardiac hypertrophy caused by ␤AR stimulation is of particular interest, as recent literature indicates that deterioration of the hypertrophied heart is linked to progressive loss of cardiomyocytes. 59 Other groups have also shown that inhibition of apoptosis is accompanied by attenuation of heart failure and cardiac hypertrophy, along with increased cardiomyocyte apoptosis prior to the development of significant heart failure. 60, 61 Taken together, modulation of apoptosis during cardiac hypertrophy as a preventive for heart failure or stroke may lead to viable therapeutic modalities in the near future.
Conclusion
Epinephrine and norepinephrine injections stimulate ␣AR and ␤AR can cause cardiac cell damage to a qualitatively similar extent. In contrast, ISO injection stimulates only ␤AR can impair the myocardium more severely. Therefore, most of the studies have focused on understanding ␤AR-mediated signal transduction mechanisms and finding targets to prevent ␤AR-mediated cardiac remodeling. More recently, ␤AR overstimulation of vascular structural and function has shown differential effects compared to that of the heart. Therefore, cerebrovascular remodeling and dysfunction reviewed in this study may give a new insight into understanding cerebral damage after ␤AR overstimulation, during long-term stress and therapeutic intervention of ␤AR overstimulation induced cardiovascular events.
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